1. Home
  2. STM vs NTRA Comparison

STM vs NTRA Comparison

Compare STM & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo STMicroelectronics N.V.

STM

STMicroelectronics N.V.

HOLD

Current Price

$41.58

Market Cap

29.9B

Sector

Technology

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$195.42

Market Cap

28.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STM
NTRA
Founded
1987
2003
Country
Netherlands
United States
Employees
49602
N/A
Industry
Semiconductors
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.9B
28.0B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
STM
NTRA
Price
$41.58
$195.42
Analyst Decision
Buy
Strong Buy
Analyst Count
4
15
Target Price
$34.25
$259.07
AVG Volume (30 Days)
7.7M
1.1M
Earning Date
04-23-2026
05-07-2026
Dividend Yield
0.79%
N/A
EPS Growth
N/A
0.65
EPS
N/A
N/A
Revenue
N/A
$210,939,000.00
Revenue This Year
$16.63
$18.08
Revenue Next Year
$12.36
$19.72
P/E Ratio
$187.61
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.55
$131.81
52 Week High
$41.44
$256.36

Technical Indicators

Market Signals
Indicator
STM
NTRA
Relative Strength Index (RSI) 75.20 46.58
Support Level $25.32 $187.47
Resistance Level N/A $204.34
Average True Range (ATR) 1.24 10.41
MACD 0.70 0.73
Stochastic Oscillator 99.57 40.01

Price Performance

Historical Comparison
STM
NTRA

About STM STMicroelectronics N.V.

A merger between Italian firm SGS Microelettronica and the nonmilitary business of Thomson Semiconducteurs in France formed STMicroelectronics in 1987. STMicroelectronics is a leader in a variety of semiconductor products, including analog chips, discrete power semiconductors, microcontrollers, and sensors. It is an especially prominent chip supplier to the industrial and automotive industries.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: